Transformation from inflamed skin to clear skin, symbolizing healing and hope.

Unlocking Clear Skin: The Latest Breakthroughs in Psoriasis and Rosacea Treatments

"Discover how new systemic treatments and patient-focused initiatives are revolutionizing care for psoriasis and rosacea sufferers."


Living with psoriasis or rosacea can feel like a constant battle. These chronic skin conditions not only affect physical appearance but can also impact self-esteem and overall quality of life. Fortunately, ongoing research and patient advocacy are paving the way for more effective and compassionate care.

For individuals with psoriasis, new targeted medications offer hope for clearer skin and lasting relief. Simultaneously, initiatives like the 'Aktiv gegen Rosacea' campaign are empowering patients to take control of their skin health journey.

This article delves into the latest breakthroughs in psoriasis and rosacea treatments, providing insights into innovative systemic therapies, the importance of patient education, and practical tips for managing these conditions.

Revolutionizing Psoriasis Treatment: The Power of Targeted Therapies

Transformation from inflamed skin to clear skin, symbolizing healing and hope.

Traditional approaches to managing moderate to severe psoriasis often involve topical treatments and conventional systemic medications. While these options can be effective for some, they may not provide adequate relief for everyone. New targeted medications, known as biologics, are transforming the treatment landscape.

One such biologic, Brodalumab (Kyntheum®), represents a significant advancement in psoriasis care. Unlike other biologics that target the cytokine IL-17A, Brodalumab selectively blocks the receptor subunit A of the IL-17 receptor. This unique mechanism of action inhibits multiple IL-17 isoforms (IL-17A, IL-17A/F, IL-17F, IL-17C, and IL-17E), which are implicated in the development of psoriasis.
  • Faster Results: Clinical trials have demonstrated that Brodalumab leads to significantly faster skin clearance compared to other treatments like ustekinumab.
  • Higher Clearance Rates: More patients achieved complete or near-complete skin clearance (PASI 100) with Brodalumab compared to ustekinumab.
  • Sustained Relief: The benefits of Brodalumab have been shown to last for up to 52 weeks, providing long-term relief from psoriasis symptoms.
Dr. Ralph von Kiedrowski highlights that if conventional systemic therapies don't yield satisfactory results, a biologic, such as Brodalumab, can be considered earlier in the treatment plan. The data indicate a significant improvement in outcomes for many patients, but individual results can vary. Discussing potential treatments and their suitability with a healthcare provider is essential.

Empowering Patients Through Education and Support

Whether you're dealing with psoriasis or rosacea, remember that you're not alone. By staying informed, seeking professional care, and connecting with others, you can take control of your skin health and live a happier, healthier life. The advancements in treatment options and the availability of patient support make it an opportune time to seek personalized solutions and embrace a proactive approach to skincare.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.